Skip to main content
RGNX logo

RGNX · REGENXBIO Inc. · Documents

Track RGNX — free
$7.16 -0.02 (-0.28%) At close · Nov 20 Play latest call Q3 2026 earnings call transcript
Market Cap
$473.44M
Shares
66.12M
Volume · Nov 20 1.06M Avg daily vol (3M) 1.38M

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

2025
Mar 13
Annual report 10-K FY2024, ended Dec 31
Annual report for FY2024
Revenue $83.33M ▼ 7.7% Net loss $227.1M Diluted EPS -$4.59
2024
Feb 27
Annual report 10-K FY2023, ended Dec 31
Annual report for FY2023
Revenue $90.24M ▼ 19.9% Net loss $263.49M Diluted EPS -$6.02
2023
Feb 28
Annual report 10-K FY2022, ended Dec 31
Annual report for FY2022
Revenue $112.72M ▼ 76.0% Net loss $280.32M Diluted EPS -$6.50
2022
Showing 51–100 of 160 documents
Key facts CIK 1590877 CUSIP 75901B107 13F (30d) 173 filings 157 filers Visit website Investor relations